BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9612190)

  • 1. Photodynamic therapy in Barrett's esophagus.
    Overholt BF; Panjehpour M
    J Clin Laser Med Surg; 1996 Oct; 14(5):245-9. PubMed ID: 9612190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy for Barrett's esophagus: clinical update.
    Overholt BF; Panjehpour M
    Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients.
    Overholt BF; Panjehpour M; Haydek JM
    Gastrointest Endosc; 1999 Jan; 49(1):1-7. PubMed ID: 9869715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy in Barrett's esophagus: reduction of specialized mucosa, ablation of dysplasia, and treatment of superficial esophageal cancer.
    Overholt BF; Panjehpour M
    Semin Surg Oncol; 1995; 11(5):372-6. PubMed ID: 7569560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma.
    Wolfsen HC; Hemminger LL; Raimondo M; Woodward TA
    South Med J; 2004 Sep; 97(9):827-30. PubMed ID: 15455964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
    Panjehpour M; Overholt BF
    Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
    Foroulis CN; Thorpe JA
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia.
    Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR
    Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy for Barrett's esophagus.
    Overholt BF; Panjehpour M
    Gastrointest Endosc Clin N Am; 1997 Apr; 7(2):207-20. PubMed ID: 9101262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy for Barrett's esophagus: a review.
    Kelty CJ; Marcus SL; Ackroyd R
    Dis Esophagus; 2002; 15(2):137-44. PubMed ID: 12220421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
    Gray J; Fullarton GM
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in esophageal motility after porfimer sodium photodynamic therapy for Barrett's dysplasia and mucosal carcinoma.
    Shah AK; Wolfsen HC; Hemminger LL; Shah AA; DeVault KR
    Dis Esophagus; 2006; 19(5):335-9. PubMed ID: 16984528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
    Gossner L; May A; Sroka R; Ell C
    Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment.
    Panjehpour M; Overholt BF; Phan MN; Haydek JM
    Gastrointest Endosc; 2005 Jan; 61(1):13-8. PubMed ID: 15672050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results.
    Overholt BF; Panjehpour M; Halberg DL
    Gastrointest Endosc; 2003 Aug; 58(2):183-8. PubMed ID: 12872083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
    Yachimski P; Mino-Kenudson M; Sherwood ME; Puricelli WP; Nishioka NS; Lauwers GY
    Virchows Arch; 2011 Dec; 459(6):581-6. PubMed ID: 22081106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.
    Overholt BF; Wang KK; Burdick JS; Lightdale CJ; Kimmey M; Nava HR; Sivak MV; Nishioka N; Barr H; Marcon N; Pedrosa M; Bronner MP; Grace M; Depot M;
    Gastrointest Endosc; 2007 Sep; 66(3):460-8. PubMed ID: 17643436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation.
    Panjehpour M; Overholt BF; Haydek JM; Lee SG
    Am J Gastroenterol; 2000 Sep; 95(9):2177-84. PubMed ID: 11007214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus.
    Gossner L; May A; Stolte M; Seitz G; Hahn EG; Ell C
    Gastrointest Endosc; 1999 Jan; 49(1):8-12. PubMed ID: 9869716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.